Monoamine Oxidase Inhibitor Interactions: An Addendum to Dr Shader's Letter
- PMID: 37930217
- DOI: 10.1097/JCP.0000000000001771
Monoamine Oxidase Inhibitor Interactions: An Addendum to Dr Shader's Letter
Comment in
-
Monoamine Oxidase Interactions. Reply to Comments by Drs. Van den Eynde and Gillman.J Clin Psychopharmacol. 2023 Nov-Dec 01;43(6):554-555. doi: 10.1097/JCP.0000000000001769. J Clin Psychopharmacol. 2023. PMID: 37930218 No abstract available.
Comment on
-
Monoamine Oxidase Interactions.J Clin Psychopharmacol. 2023 Jul-Aug 01;43(4):393. doi: 10.1097/JCP.0000000000001718. Epub 2023 Jun 19. J Clin Psychopharmacol. 2023. PMID: 37335191 No abstract available.
References
-
- Van den Eynde V, Abdelmoemin WR, Abraham MM, et al. The prescriber's guide to classic MAO inhibitors (phenelzine, tranylcypromine, isocarboxazid) for treatment-resistant depression. CNS Spectr. 2022;1–14.
-
- Gillman PK. Tricyclic antidepressant pharmacology and therapeutic drug interactions updated. Br J Pharmacol. 2007;151:737–748.
-
- Gillman PK. CNS toxicity involving methylene blue: the exemplar for understanding and predicting drug interactions that precipitate serotonin toxicity. J Psychopharmacol. 2011;25:429–433.
-
- Buckley NA, Dawson AH, Isbister GK. Serotonin syndrome. BMJ. 2014;348:g1626. doi: 10.1136/bmj.g1626. - DOI
-
- Shader RI. Monoamine oxidase interactions. J Clin Psychopharmacol. 2023;43:393.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
